Nanobody-based CAR-T cells for cancer immunotherapy

Chimeric antigen receptor T-cell (CAR-T) therapy is the result of combining genetic engineering-based cancer immunotherapy with adoptive cell therapy (ACT). CAR-T therapy has been successful in treating various types of hematological cancers. CARs are receptors made of an extracellular domain, a mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pouya, Naseri, Abdolhossein, Mirarefin, Seyed Mohamad Javad, Salem, Faeze, Nikbakht, Mojtaba, Evazi Bakhshi, Sahar, Safarzadeh Kozani, Pooria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036779/
https://www.ncbi.nlm.nih.gov/pubmed/35468841
http://dx.doi.org/10.1186/s40364-022-00371-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036779/
https://www.ncbi.nlm.nih.gov/pubmed/35468841
http://dx.doi.org/10.1186/s40364-022-00371-7

Ejemplares similares